With communities of color disproportionately impacted by COVID-19, drugmakers and public health officials are placing an unprecedented emphasis on diversity in vaccine clinical trials.
Beau Garland, Vice President of Recruitment, Meridian Clinical Research
Jonathan Jackson, PhD, Director, CARE Research Center, Massachusetts General Hospital.
For complete complete transcript of this conversation: https://tradeoffs.org/2020/10/27/good-intentions/
To stay on top of all our coverage of the coronavirus and our conversations with people who are being forced to make difficult decisions in the midst of it all, visit http://bit.ly/coronavirustradeoffs.
Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletter
Follow us on Twitter: https://twitter.com/tradeoffspod
See acast.com/privacy for privacy and opt-out information.